Targeting eIF4F translation complex sensitizes B-ALL cells to tyrosine kinase inhibition
Abstract The mechanistic target of rapamycin (mTOR) is a kinase whose activation is associated with poor prognosis in pre-B cell acute lymphoblastic leukemia (B-ALL). These and other findings have prompted diverse strategies for targeting mTOR signaling in B-ALL and other B-cell malignancies. In cel...
Guardado en:
Autores principales: | Thanh-Trang Vo, Lee-or Herzog, Roberta Buono, Jong-Hoon Scott Lee, Sharmila Mallya, Madeleine R. Duong, Joshua Thao, Moran Gotesman, David A. Fruman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f6da06c10adf41ed853a873822db0706 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dysregulation of Translation Factors EIF2S1, EIF5A and EIF6 in Intestinal-Type Adenocarcinoma (ITAC)
por: Christoph Schatz, et al.
Publicado: (2021) -
The structural basis of translational control by eIF2 phosphorylation
por: Tomas Adomavicius, et al.
Publicado: (2019) -
Zotatifin, an eIF4A-Selective Inhibitor, Blocks Tumor Growth in Receptor Tyrosine Kinase Driven Tumors
por: Adina Gerson-Gurwitz, et al.
Publicado: (2021) -
Structural basis for the inhibition of translation through eIF2α phosphorylation
por: Yuliya Gordiyenko, et al.
Publicado: (2019) -
Translational repression of NMD targets by GIGYF2 and EIF4E2.
por: Boris Zinshteyn, et al.
Publicado: (2021)